10 Best Future Stocks to Buy for the Next 5 Years
On March 25, Scott Chronert of Citi joined 'Closing Bell' on CNBC to discuss whether it is time to enter the market and if recent presidential actions have changed the market dynamic.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 4,606,327 | $4,950,328,353 | +4% | 1.69% |
| 2. | 2,236,400 | $2,403,414,352 | -4% | 0.36% | |
| 3. | 2,088,800 | $2,244,791,584 | -7% | 0.34% | |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,208,336 | $1,298,574,533 | +641% | 1.18% |
| 5. | Adage Capital Management Phill Gross And Robert Atchinson | 832,292 | $894,447,567 | +4% | 1.35% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $691.79 | 715 | $494,626.99 | 14,685 | 2025-08-15 | Filing | |
| $660.25 | 758 | $500,472.53 | 758 | 2025-08-13 | Filing | |
| $647.36 | 1,000 | $647,360.00 | 20,562 | 2025-08-13 | Filing | |
| $644.77 | 1,632 | $1,052,263.01 | 546,601 | 2025-08-12 | Filing | |
| $634.41 | 1,000 | $634,405.00 | 137,660 | 2025-08-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1,116.69 | 2,737 | $3,056,369.58 | 91,896,978 | 2026-01-07 | Filing | |
| $1,115.76 | 2,210 | $2,465,831.81 | 91,899,715 | 2026-01-07 | Filing | |
| $1,114.37 | 4,342 | $4,838,603.22 | 91,901,925 | 2026-01-07 | Filing | |
| $1,113.77 | 9,053 | $10,082,968.86 | 91,906,267 | 2026-01-07 | Filing | |
| $1,112.43 | 4,652 | $5,175,038.32 | 91,915,320 | 2026-01-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 20,897 | $19,220,434 | 1.91% | |
| 2. | 15,230 | $14,008,177 | 2.84% | |
| 3. | 5,327 | $4,899,615 | 1.17% | |
| 4. | 3,757 | $3,455,548 | 1.16% | |
| 5. | 2,590 | $2,382,205 | 0.19% |
News See All
11 Stocks in Focus: Jim Cramer on NVIDIA, Callers’ Picks, and Recent AI Data Center Rally
In this article, we will look at stocks recently featured on Mad Money, as Jim Cramer analyzed the broader market impact of the recent AI data center rally.
8 Best US Stocks to Buy and Hold for the Next 3 Years
On March 30, Strategas Research Partners chairman & CEO Jason Trennert joined 'Squawk Box' on CNBC to discuss whether escalating geopolitical tensions could derail strong markets and the state of the ...
7 Best Pharma Stocks to Invest In Now
On March 24, Scott Chronert, Citi, appeared on CNBC’s 'Closing Bell' to talk about the market and whether it is time to get into equity markets.
Eli Lilly and Company (LLY) Continued to Gain from Its Incretin Portfolio
Bristol Gate Capital Partners, an investment management company, published its Q4 2025 investor letter for the “US Equity Strategy”. A copy of the letter can be downloaded here.
Jim Cramer's Hottest GLP-1 and Weight Loss Stock Picks
In an appearance on CNBC's Fast Money in January, Ray Stevens, CEO of Structure Therapeutics, discussed the unmet potential in the obesity market.
9 Good Stocks to Buy Now
On March 21, Tom Lee, CIO at Fundstrat, appeared on a CNBC Television interview to discuss the market potential amid the war.
Janus Henderson Forty Fund’s Updates on Eli Lilly and Company (LLY)
Janus Henderson Investors, an investment management company, released its “Forty Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S.
Eli Lilly (LLY) Gained From Growth in its GLP-1 Franchises Drugs
RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark Large Growth Fund” Q4 2025 investor letter.
Morgan Stanley Reiterates Overweight on Eli Lilly (LLY), Cites Growth Potential of New Platform
Eli Lilly & Company (NYSE:LLY) ranks among the best high profit margin stocks to buy.
Hedge Fund Resource Center